Abstract:In a subset of patients, chronic exposure to stress is an etiological risk factor for neuroinflammation and depression. Neuroinflammation affects up to 27% of patients with MDD and is associated with a more severe, chronic, and treatment-resistant trajectory. Inflammation is not unique to depression and has transdiagnostic effects suggesting a shared etiological risk factor underlying psychopathologies and metabolic disorders. Research supports an association but not necessarily a causation with depression. Putative mechanisms link chronic stress to dysregulation of the HPA axis and immune cell glucocorticoid resistance resulting in hyperactivation of the peripheral immune system. The chronic extracellular release of DAMPs and immune cell DAMP-PRR signaling creates a feed forward loop that accelerates peripheral and central inflammation. Higher plasma levels of inflammatory cytokines, most consistently interleukin IL-1β, IL-6, and TNF-α, are correlated with greater depressive symptomatology. Cytokines sensitize the HPA axis, disrupt the negative feedback loop, and further propagate inflammatory reactions. Peripheral inflammation exacerbates central inflammation (neuroinflammation) through several mechanisms including disruption of the blood-brain barrier, immune cellular trafficking, and activation of glial cells. Activated glial cells release cytokines, chemokines, and reactive oxygen and nitrogen species into the extra-synaptic space dysregulating neurotransmitter systems, imbalancing the excitatory to inhibitory ratio, and disrupting neural circuitry plasticity and adaptation. In particular, microglial activation and toxicity plays a central role in the pathophysiology of neuroinflammation. Magnetic resonance imaging (MRI) studies most consistently show reduced hippocampal volumes. Neural circuitry dysfunction such as hypoactivation between the ventral striatum and the ventromedial prefrontal cortex underlies the melancholic phenotype of depression. Chronic administration of monoamine-based antidepressants counters the inflammatory response, but with a delayed therapeutic onset. Therapeutics targeting cell mediated immunity, generalized and specific inflammatory signaling pathways, and nitro-oxidative stress have enormous potential to advance the treatment landscape. Future clinical trials will need to include immune system perturbations as biomarker outcome measures to facilitate novel antidepressant development. In this overview, we explore the inflammatory correlates of depression and elucidate pathomechanisms to facilitate the development of novel biomarkers and therapeutics.

The Relationship between Neurobiological Function and Inflammation in Depressed Children and Adolescents: A Scoping Review

Inflammatory biomarkers in depression: scoping review

Annual Research Review: Neuroimmune network model of depression: a developmental perspective

Neuroinflammation and depression: A review

Pharmacological anti-inflammatory treatment in children and adolescents with depressive symptoms: A systematic-review and meta-analysis

Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications

Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology

Cerebrovascular Dysfunction And Depressive Symptoms In Pre-Clinical Models: Insights From A Scoping Review

Inflammation and immune system pathways as biological signatures of adolescent depression—the IDEA-RiSCo study

Gut Microorganisms, Neuroinflammation and Behavioral Changes

Executive functioning mediates the association between inflammation and 12-month depression-onset during adolescence

Elevated Systemic Inflammation Is Associated with Reduced Corticolimbic White Matter Integrity in Depression

Cytokines Mediated Inflammation and Decreased Neurogenesis in Animal Models of Depression

Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder

Peripheral Cytokine Levels and Response to Antidepressant Treatment in Depression: a Systematic Review and Meta-Analysis

Higher Levels of Pro-inflammatory Cytokines Are Associated With Higher Levels of Glutamate in the Anterior Cingulate Cortex in Depressed Adolescents

Obesity, inflammation, and depression in adolescents

Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories

The inflammatory underpinning of depression: An historical perspective

Inflammation and Decreased Functional Connectivity in a Widely-Distributed Network in Depression: Centralized Effects in the Ventral Medial Prefrontal Cortex

- Association of Neuropsychiatric Symptoms with Inflammation: Review Findings from the Workshop on Brain Immune Interactions